Atlas FDA

HemoCue Glucose 201 Microcuvettes, The HemoCue Glucose 201 Microcuvettes are designed for use with the HemoCue Glucose 2

FDA device recall Z-0873-2015 · posted 2014-12-24 · Terminated

Recall details

Recalling firm
Radiometer America Inc
Reason for recall
Batches of HemoCue Glucose 201 Microcuvettes show discoloration and provide results outside the specification at the end of their shelf life, approx. after 6 months. The HemoCue Glucose 201 Analyzer with plasma conversion multiplies the measured whole blood glucose value by a factor of 1.11 and displays a plasma equivalent glucose result. HemoCue Glucose 201 Microcuvettes are for In Vitro Diag
Action taken
The consignees will be notified by a Field Safety Notice. Distributors will be instructed to forward the Field Safety Notice to their end customers and to secure that verification forms will be filled-out by end customers and returned to HemoCue.
Root cause
Under Investigation by firm
Status
Terminated
Product code
CGA
Quantity affected
3,712,900 microcuvettes
Distribution
Worldwide Distribution-US (nationwide) and the countries of Canada, Austria, AUSTRALIA, SWITZERLAND, COTE D'IVOIRE, CYPRUS, CZECH REPUBLIC, GERMANY, DENMARK, FINLAND, FRANCE, UNITED KINGDOM, GEORGIA,
Date initiated
2014-10-20
Date posted
2014-12-24
Date terminated
2015-10-02
Location
Westlake, OH

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
HEMOCUE GLUCOSE 201 SYSTEM, ARTICLE NUMBER 120706 (K020935)Hemocue, Inc.2002-04-03